Lunasin Peptide Cholesterol Reduction via Histone Acetylation Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for lowering cholesterol levels using soy products are not targeted or highly effective, and it is unclear which component of soybeans provides hypocholesterolemic effects, with varying results due to the need for large amounts of soy consumption and unclear mechanisms of action.
Innovation Solution
Development of compositions comprising lunasin, a biologically active soy peptide, which inhibits histone H3 acetylation and increases LDL receptor expression, thereby reducing cholesterol levels, and the use of soy flour to protect lunasin from digestion and enhance its bioavailability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If large amounts of soy products are consumed to lower cholesterol levels, then cholesterol reduction effect is achieved, but the complexity of diet management and potential side effects increase
Solution Approach 1:
The patent extracts lunasin, the specific bioactive peptide responsible for cholesterol-lowering effects, from whole soy products. This isolation allows the active component to be delivered in concentrated form without requiring consumption of large quantities of whole soy products, thereby resolving the contradiction between achieving reliable cholesterol reduction and maintaining ease of diet management.
Solution Approach 2:
The patent changes the concentration parameter of the active ingredient by providing lunasin in purified and concentrated forms (e.g., 50-90% lunasin purity). This parameter change enables achieving the same therapeutic effect with much smaller doses, simplifying diet management while maintaining reliability of cholesterol reduction.
2Ease of manufacture
If whole soy products are used to lower cholesterol, then the source material is readily available, but the efficacy varies due to unclear active components and mechanisms
Solution Approach 1:
The patent extracts and identifies lunasin as the specific active component responsible for cholesterol-lowering effects. By isolating this single peptide from complex soy matrices, the patent eliminates the variability inherent in whole soy products while maintaining the benefit of using soy as the source material. This resolves the contradiction between ease of manufacture and reliable efficacy.
Solution Approach 2:
The patent applies local quality by focusing on the specific bioactive region (lunasin peptide) within the soy protein structure rather than treating the entire soy product as a homogeneous substance. This targeted approach ensures consistent delivery of the active component, resolving the efficacy variability problem while still utilizing soy as the source.
3Reliability
If soy peptides are used to lower cholesterol, then the active component is identified, but the peptides are degraded during digestion reducing bioavailability
Solution Approach 1:
The patent employs preliminary action by pre-coating lunasin peptides with soy flour or other protective carriers before ingestion. This preliminary protective measure prevents degradation during the digestive process, ensuring that sufficient quantities of the identified active component reach the bloodstream in bioavailable form, thus resolving the contradiction between identifying the active component and maintaining its quantity.
Solution Approach 2:
The patent applies beforehand cushioning by using soy flour matrices to protect lunasin peptides from enzymatic degradation in the gastrointestinal tract. This protective cushioning ensures that the identified active component survives digestion and maintains its bioavailability, resolving the contradiction between active component identification and quantity preservation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The lunasin-based compositions effectively lower total and LDL cholesterol levels, providing a more concentrated and feasible way to achieve cholesterol-lowering benefits compared to existing soy products, with improved efficacy and bioavailability.
Implementation Method 1
lunasin, a biologically active soy peptide, which inhibits histone H3 acetylation and increases LDL receptor expression
Implementation Method 2
the use of soy flour to protect lunasin from digestion and enhance its bioavailability
Data Source
AI summary
Controlled studies demonstrate that products and related methods using soy related peptides lower total and LDL cholesterol levels in individuals. In one exemplary embodiment of the present disclosure, a product containing an effective amount of lunasin peptides that lowers cholesterol levels in an individual that consumes the lunasin peptides is provided. In another exemplary embodiment of the present disclosure, a composition containing an effective amount of lunasin peptides or lunasin peptide derivatives and one or more enzyme inhibitors is provided. In a related exemplary embodiment of the present disclosure, a method for lowering or reducing cholesterol levels in an individual is provided where a product containing an effective amount of lunasin peptides to an individual is provided and a claim that the product lowers or reduces cholesterol, total cholesterol, LDL cholesterol or lipid levels in an individual that consumes the composition is made.